• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
  

PubMed=15902309; DOI=10.1172/JCI23002; PMCID=PMC1090471
Tai I.T., Dai M., Owen D.A., Chen L.-B.
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
J. Clin. Invest. 115:1492-1502(2005)

PubMed=20835245; DOI=10.1038/nmeth.1503
Griffith M., Griffith O.L., Mwenifumbo J., Goya R., Morrissy A.S., Morin R.D., Corbett R.D., Tang M.J., Hou Y.-C., Pugh T.J., Robertson G., Chittaranjan S., Ally A., Asano J.K., Chan S.Y., Li H.-Y.I., McDonald H., Teague K., Zhao Y.-J., Zeng T., Delaney A., Hirst M., Morin G.B., Jones S.J.M., Tai I.T., Marra M.A.
Alternative expression analysis by RNA sequencing.
Nat. Methods 7:843-847(2010)

PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)